Our Services
Medical Information
Helpful Resources
Published on: 9/23/2026
Most adults need a single dose of the current season's updated COVID-19 vaccine, while adults 65 and older and those who are moderately or severely immunocompromised are often advised to get an additional dose roughly six months later. Adults who have never been vaccinated typically begin with one updated dose, though some immunocompromised adults require a multi-dose series with specific spacing. Timing can also shift based on a recent infection, pregnancy, and which manufacturer you receive, so there are several important factors to consider. See below for the complete dose-by-dose breakdown, recommended intervals, and who qualifies for extra doses. If you are unsure whether you are due for a dose, or you feel unwell and cannot tell whether it is a vaccine reaction, a cold, or COVID itself, a free, instant, online symptom check can help you make sense of your symptoms in minutes and guide your next steps with more confidence.
Last reviewed for medical accuracy: 09/23/2026
Staying up to date with the COVID vaccine schedule is one of the best ways to protect yourself and those around you. Science shows that vaccination reduces severe illness, hospitalization and the risk of long-term complications. This guide lays out current recommendations for adults (18 years and older), including primary doses, boosters and considerations for people with weakened immune systems. Always check with your healthcare provider to confirm timing, especially if you have medical conditions or are taking other medications.
Most adults begin with a “primary series” of COVID-19 vaccines. Two main types are in widespread use:
mRNA vaccines (Pfizer-BioNTech or Moderna)
Viral vector vaccine (Janssen/Johnson & Johnson)
Key points:
Adults with moderate to severe immunocompromise (for example, active cancer treatment, organ transplant recipients, advanced HIV) should receive an extra primary mRNA dose:
The COVID virus continues to evolve. Updated “bivalent” boosters target both the original strain and newer variants (for example, Omicron sublineages). Current guidance:
As immunity wanes over time, some adults may choose—or be recommended—to get a second bivalent booster:
If you’re under 65 and healthy, a second booster is optional. If you’re in a higher-risk group, talk with your doctor about whether you should get it.
Flexibility is allowed:
Mild side effects are normal — they mean your body is building protection. Common reactions include:
These usually resolve within 1–3 days. Over-the-counter pain relievers can help. Severe allergic reactions are very rare; vaccination sites are equipped to manage them.
Guidelines may evolve as new data emerge. Reliable places to check for updates include your national public health agency or your healthcare provider. They’ll have the latest on variant-specific boosters or new vaccine formulations.
If you experience unusual or severe symptoms after vaccination — such as chest pain, leg swelling, severe headache or difficulty breathing — seek medical attention right away. For non-urgent health checks or to explore symptoms you’re worried about, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Remember: this overview does not replace professional medical advice. Always speak to a doctor about any life-threatening or serious symptoms, or if you have questions about how COVID vaccination fits into your overall health plan.
Keeping up with the COVID vaccine schedule ensures you have the best possible protection against severe disease. Talk with your healthcare provider about any concerns, and follow the timing recommendations that apply to your health status and risk factors. Your immunity, and the health of your community, depend on staying current with vaccination.
(References)
* Soyfer V, Gutfeld O, Shamai S, Schlocker A, Merimsky O. COVID-19 Vaccine-Induced Radiation Recall Phenomenon. Int J Radiat Oncol Biol Phys. 2021 Jul 15;110(4):957-961. doi: 10.1016/j.ijrobp.2021.02.048. Epub 2021 Mar 4. PMID: 33677050; PMCID: PMC7930806.
* Belda-Iniesta C. Optimising SARS-CoV-2 vaccination schedules. Lancet. 2021 Sep 4;398(10303):819-821. doi: 10.1016/S0140-6736(21)01729-3. Epub 2021 Aug 6. PMID: 34370969; PMCID: PMC8346239.
* Arroyo-Sánchez D, Cabrera-Marante O, Laguna-Goya R, Almendro-Vázquez P, Carretero O, Gil-Etayo FJ, Suàrez-Fernández P, Pérez-Romero P, Rodríguez de Frías E, Serrano A, Allende LM, Pleguezuelo D, Paz-Artal E. Immunogenicity of Anti-SARS-CoV-2 Vaccines in Common Variable Immunodeficiency. J Clin Immunol. 2022 Feb;42(2):240-252. doi: 10.1007/s10875-021-01174-5. Epub 2021 Nov 17. PMID: 34787773; PMCID: PMC8596355.
* Kaku CI, Champney ER, Normark J, Garcia M, Johnson CE, Ahlm C, Christ W, Sakharkar M, Ackerman ME, Klingström J, Forsell MNE, Walker LM. Broad anti-SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1/mRNA-1273 vaccination. Science. 2022 Mar 4;375(6584):1041-1047. doi: 10.1126/science.abn2688. Epub 2022 Feb 10. PMID: 35143256; PMCID: PMC8939765.
* Hervius Askling H, Gisslén M. Rekommendationer för vaccin mot covid-19 borde förtydligas. Lakartidningen. 2022 Sep 30;119. Epub 2022 Sep 30. PMID: 36178271.
* Greenberg GM, Koshy PA, Hanson MJS. Adult Vaccination. Am Fam Physician. 2022 Nov;106(5):534-542. PMID: 36379499.
* Graña C, Ghosn L, Evrenoglou T, Jarde A, Minozzi S, Bergman H, Buckley BS, Probyn K, Villanueva G, Henschke N, Bonnet H, Assi R, Menon S, Marti M, Devane D, Mallon P, Lelievre JD, Askie LM, Kredo T, Ferrand G, Davidson M, Riveros C, Tovey D, Meerpohl JJ, Grasselli G, Rada G, Hróbjartsson A, Ravaud P, Chaimani A, Boutron I. Efficacy and safety of COVID-19 vaccines. Cochrane Database Syst Rev. 2022 Dec 7;12(12):CD015477. doi: 10.1002/14651858.CD015477. Epub 2022 Dec 7. PMID: 36473651; PMCID: PMC9726273.
* Poukka E, Andersson NW, Thiesson EM, Baum U, Pihlström N, Perälä J, Kristoffersen AB, Meijerink H, Starrfelt J, Ljung R, Hviid A. COVID-19 Vaccine Effectiveness Among Adolescents. Pediatrics. 2024 Jan 1;153(2). doi: 10.1542/peds.2023-062520. PMID: 38196395.
* Faksova K, Walsh D, Jiang Y, Griffin J, Phillips A, Gentile A, Kwong JC, Macartney K, Naus M, Grange Z, Escolano S, Sepulveda G, Shetty A, Pillsbury A, Sullivan C, Naveed Z, Janjua NZ, Giglio N, Perälä J, Nasreen S, Gidding H, Hovi P, Vo T, Cui F, Deng L, Cullen L, Artama M, Lu H, Clothier HJ, Batty K, Paynter J, Petousis-Harris H, Buttery J, Black S, Hviid A. COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals. Vaccine. 2024 Apr 2;42(9):2200-2211. doi: 10.1016/j.vaccine.2024.01.100. Epub 2024 Feb 12. PMID: 38350768.
* Walbert H. Wie Sie gut organisiert in die Impfsaison gehen. MMW Fortschr Med. 2024 Oct;166(16):35. doi: 10.1007/s15006-024-4145-3. PMID: 39322893.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.